Our Experience
To date there have been more than 400 clinical trials conducted at TTMC’s sites in the past ten years. Among them, 90% are global trials, 95% are multi-center projects, and about half are early phase (II and IIIa) studies for NDA submission purpose. Our clients include international pharmaceutical companies, contracted research organizations (CROs), medical device companies, and biotechnology companies.
Clients
|
|